NJ Reaveal©

NJ Reveal© used to assist in gradual weight management, digestive pacing, and sustainable metabolic adjustment. This classic selective GLP-1 peptide slows stomach emptying and signals lasting fullness to the brain, vital to maintaining your new body.

NJ.Reveal© -Paces digestion and increases post-meal satiety . -Supports gentle, gradual appetite control and portion management . -Exceptional safety profile for first-time peptide users .

Indications:

-Moderate weight management

-Satiety delay and portion control

-Starting peptide therapy accommodation

-Cardiovascular health and biomarker enhancement

Injection technique :
Injection should be administered via subcutaneous route at a depth of 4-6mm. Injection is given once weekly. Cleanse the skin with alcohol. Starting dosage is 0.25mg (15 units on a 100-unit syringe of 5.1mg/3.0ml vial) weekly for 4 weeks, escalating to 0.50mg (30 units) weekly for the subsequent 4 weeks.

Post care management :
– Avoid heavy or late-night dinners to minimize morning stomach fullness and acid reflux.

– Engage in light physical activity (like a short walk) after eating to support digestive motility.

– Manage temporary symptoms using herbal teas (ginger, peppermint) or medical antiemetics as directed by your physician.